BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates

  February 25, 2026

   · 

  30 min read
• Press Releases

  Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results

  February 25, 2026

   · 

  18 min read
• Press Releases

  Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  February 25, 2026

   · 

  18 min read
• Press Releases

  Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

  February 25, 2026

   · 

  9 min read
• Press Releases

  Bicara Therapeutics Announces Proposed Public Offering of Common Stock

  February 25, 2026

   · 

  6 min read
• Press Releases

  Palvella Therapeutics Announces Proposed Public Offering

  February 25, 2026

   · 

  5 min read
• Press Releases

  Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

  February 25, 2026

   · 

  17 min read
• Press Releases

  AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

  February 25, 2026

   · 

  2 min read
• Press Releases

  GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

  February 25, 2026

   · 

  1 min read
• Press Releases

  Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

  February 25, 2026

   · 

  13 min read